Analytics & Reports
Revenue cycle analytics, coding patterns, and optimization opportunities.
88
Monthly Encounters
$38,200
Monthly Revenue
$434
Avg $/Encounter
4.2%
Denial Rate
68%
Appeal Win Rate
94.3%
Compliance Avg
Revenue Trend
Last 6 monthsDenial Rate Trend
Denial rate decreased from 9.2% to 4.2% since adopting MedveriCodex
E/M Code Distribution
This month14 encounters may support higher E/M level — $4,200 potential recovery.
Payer Denial Comparison
Last 90 daysDenial rate and average days to payment by insurer.
Medicare Part B
4.8% denial rateBlue Cross Blue Shield
7.1% denial rateAetna
9.1% denial rateUnitedHealthcare
11.1% denial rateRevenue Optimization
Monthly reportE/M undercoding analysis, modifier optimization, and add-on recovery.
Undercoding Opportunities
Encounters that may support higher E/M levels
14
encounters
Potential Revenue Recovery
Estimated value of undercoding corrections
$4,200
estimated
HCC Gap Analysis
Monthly reportMedicare Advantage risk adjustment gaps and RAF weight recapture.
3
Open Gaps
0.897
Potential RAF
Karen Taylor — HCC 40
Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
Thomas Brown — HCC 72
Polyneuropathy
Dorothy Wilson — HCC 59
Major Depressive, Bipolar, and Paranoid Disorders
Robert Johnson — HCC 40
Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
Top Denial Reasons
Monthly reportRoot cause analysis of denied claims by category.
Predictive Revenue Forecast
Weekly report90-day forecasting with what-if scenarios and anomaly detection.
Mar 2026
Confidence: High
$58,200
Apr 2026
Confidence: Medium
$61,400
May 2026
Confidence: Low
$63,100